MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$5,395K
Free Cash flow
-$13,254K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accrued expenses and other liabi...
Share-based compensation expense
Inventory
Others
Negative Cash Flow Breakdown
Net loss
Repayment of related party notes
Repayment of merchant cash advan...
Others
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Cash Flow
2025-12-31
Capital expenditures
0
Rebound asset acquisition
0
Proceeds from sanuwave convertible note receivable
0
Net cash provided by investing activities
0
Proceeds from warrants and short-term debt - related parties
0
Proceeds from issuance of short-term debt - unaffiliated
0
Repayment of short-term debt - unaffiliated
0
Payment of sepa commitment fee
0
Transaction costs related to the issuance of promissory notes with warrants
40
Proceeds from issuance of promissory notes with warrants
10,000
Proceeds from the sale of common stock in june 2025 pipe
1,035
Proceeds from the sale of common stock and warrants in july 2025 pipe
2,000
Proceeds from related party note with ktl warrant
6,812
Proceeds from the exercise of stock options
108
Cash proceeds from merchant cash advance
3,286
Repayment of merchant cash advance
2,588
Proceeds from the exercise of warrants by dragasac
2,460
Repayment of short-term debt - related party
121
Proceeds from issuance of preferred stock with warrants in pipe offering
2,000
Transaction costs from issuing of preferred stock with warrants in pipe offering
210
Tax withholding on vesting of restricted stock units
193
Repayment of related party notes
5,900
Net cash provided by financing activities
18,649
Issuance of common stock to palantir as consideration for settlement agreement
0
Issuance of common stock to yorkville for debt extension and sepa commitment fee
0
Change in fair value of contingent stock consideration
0
Other, net
0
Accrued r&d software
0
Depreciation and amortization
7,295
Non cash lease expense
110
Gain on amortization of licensing obligation
1,911
Provision for credit losses
1,353
Change in fair value of warrant liabilities
3,318
Change in fair value of derivative liability
65
Inventory reserve for obsolescence
102
Impairment of preferred stock investment
2,890
Loss on issuance of common stock to yorkville in connection with the side letter
382
Loss on issuance of common stock in connection with the settlement of debt
73
Issuance of warrants for strategic advisory agreement
1,259
Issuance of common stock due to strategic advisory agreement
108
Loss on issuance of convertible note with warrants
-2,335
Issuance of warrants to preferred stockholders in consideration of forbearance agreement
49
Gain on forgiveness of interest
991
Share-based compensation expense
10,378
Director fees paid with rsus
264
Issuance of common stock for consulting expense
705
Loss on extinguishment of debt
-6,356
Change in fair value of debt
1,809
Non cash interest expense
4,915
Accounts receivable
-7,551
Inventory
-10,246
Prepaid expenses and other assets
40
Accounts payable
3,126
Accrued expenses and other liabilities
13,452
Lease liabilities
350
Deferred income tax liabilities
3
Deferred revenue
-1,091
Net loss
-91,716
Inventory impairment
4,335
Net cash used in operating activities
-13,254
Net increase (decrease) in cash, cash equivalents and restricted cash
5,395
Net increase (decrease) in cash, cash equivalents and restricted cash
5,395
Cash, cash equivalents and restricted cash at beginning of year
10,977
Cash, cash equivalents and restricted cash at end of year
16,372
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
promissory notes with...
$10,000K
Proceeds from related
party note with ktl...
$6,812K
Cash proceeds from
merchant cash advance
$3,286K
Proceeds from the
exercise of warrants by...
$2,460K
Proceeds from issuance of
preferred stock with...
$2,000K
Proceeds from the sale of
common stock and...
$2,000K
Proceeds from the sale of
common stock in june...
$1,035K
Proceeds from the
exercise of stock options
$108K
Net cash provided by
financing activities
$18,649K
Canceled cashflow
$9,052K
Net increase
(decrease) in cash, cash...
$5,395K
Canceled cashflow
$13,254K
Repayment of related party
notes
$5,900K
Repayment of merchant cash
advance
$2,588K
Transaction costs from
issuing of preferred...
$210K
Tax withholding on
vesting of restricted...
$193K
Repayment of short-term
debt - related party
$121K
Transaction costs related to
the issuance of...
$40K
Accrued expenses and
other liabilities
$13,452K
Share-based compensation
expense
$10,378K
Inventory
-$10,246K
Accounts receivable
-$7,551K
Depreciation and
amortization
$7,295K
Loss on
extinguishment of debt
-$6,356K
Non cash interest
expense
$4,915K
Inventory impairment
$4,335K
Change in fair value of
warrant liabilities
$3,318K
Accounts payable
$3,126K
Impairment of preferred
stock investment
$2,890K
Loss on issuance of
convertible note with...
-$2,335K
Change in fair value of
debt
$1,809K
Provision for credit
losses
$1,353K
Issuance of warrants for
strategic advisory...
$1,259K
Issuance of common stock
for consulting...
$705K
Loss on issuance of
common stock to...
$382K
Lease liabilities
$350K
Director fees paid with
rsus
$264K
Non cash lease
expense
$110K
Issuance of common stock
due to strategic...
$108K
Loss on issuance of
common stock in...
$73K
Issuance of warrants to
preferred stockholders in...
$49K
Deferred income tax
liabilities
$3K
Net increase
(decrease) in cash, cash...
$5,395K
Net cash used in
operating activities
-$13,254K
Canceled cashflow
$82,662K
Net loss
-$91,716K
Gain on amortization
of licensing...
$1,911K
Deferred revenue
-$1,091K
Gain on forgiveness
of interest
$991K
Inventory reserve for
obsolescence
$102K
Change in fair value of
derivative liability
$65K
Prepaid expenses and
other assets
$40K
Buy us a coffee
Celularity Inc (CELUW)
Celularity Inc (CELUW)